News

Even with significant expansion in the global market for antibodies used in clinical care and research, scientists recognize that there is still untapped potential for finding new antibodies.
AI is enabling the development of a next generation of drugs that can more precisely target cancer cells while sparing ...
An asthma medication called omalizumab can stop your body from having an allergic response to pollen and even food.
Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.
Emerging biotech leader AKESF develops Ivonescimab & Cadonilimab; while offering growth potential with US partnerships, ...
More than 100 federal scientists who track bird flu, including vaccine and food safety experts, have been laid off. This comes as the deadly pathogen rips through dairy herds and poultry flocks.
Understanding allergies, from symptoms to treatment, genetics to environmental factors, and the likelihood of twins sharing ...
Whooping cough, or pertussis, was once a leading cause of death for children in the U.S. and worldwide before the ...
To treat glioblastoma, Purdue researchers are developing antibody-based immunotherapies to improve the recruitment and ...
Get Instant Summarized Text (Gist) Fusing two immune system proteins, BTLA and HVEM, enhances stability during immunization, enabling the generation of monoclonal antibodies. This method allows ...
WEHI scientists discovered a drug that blocks long COVID in mice and may improve acute treatment options beyond current ...
Antibody-drug conjugates combined with immunotherapy have redefined the standard of care for advanced bladder cancer, replacing single-agent treatments. An international team of researchers has ...